12/05/2026
Most people look at Big Caring Group's IPO and see a pharmacy chain going public.
We see something more interesting than that.
626 outlets. Five brands. Malaysia's largest pharmacy network. Those are the headlines, and they matter. But the story that actually justifies a premium valuation is happening below the surface, in the infrastructure that most investors won't look at closely enough.
Here's the thing about the CARiNG acquisition in 2023: BCG didn't just buy a store network from 7-Eleven Malaysia. They inherited an entirely different technology stack, different inventory systems, and a different customer data architecture. Multiply that across BIG, CARiNG, Georgetown, Wellings, and Ting, and what you have is a holding company that operated more like a loose federation of pharmacies than a unified platform.
That's the classic post-merger integration trap. And how a company handles it tells you almost everything about the quality of management.
BCG's answer was to go enterprise-grade. They adopted RISE with SAP on AWS, a cloud-based ERP and data platform to consolidate operations across their entire network into one system. This is not a small decision. It's the kind of infrastructure commitment you make when you're building for the next decade, not the next quarter.
And critically, they did it before the IPO. That sequencing matters more than most people realize.
Then there's the new Klang distribution centre, and this one deserves attention.
More than 160 robots. 700 high-density storage racks. Over 90,000 order lines processed daily. Since implementation, picking efficiency has improved by 76.5%, with picking accuracy hitting 99.8%. That's not a marketing stat, that's the kind of operational metric that shows up in margins and working capital cycles.
The facility also runs AI-driven smart replenishment that analyses real-time sales patterns by location to anticipate demand before it peaks. Tote-to-person systems for slower-moving items. Shelf-to-person for fast movers. And its location near Port Klang strengthens inbound supply chain efficiency for nationwide distribution.
Why does all this matter for investors?
Because the real value driver in pharmacy retail over the next decade isn't store count. It's who controls the data, and who can act on it. More stores generate richer data. Richer data improves replenishment, targeting, and customer experience. Better experience makes the network harder to dislodge. That's a compounding flywheel, and flywheels are what justify platform multiples rather than retail multiples.
BCG invested in this infrastructure before going public. That's either very good capital discipline or very good storytelling. The prospectus will tell us which specifically, watch for how these investments flow through to inventory turnover, operating margins, and working capital efficiency.
Do you think the market is pricing in BCG's digital transformation, or is it still being valued primarily as a traditional pharmacy roll-up?
Disclaimer: This post represents the views and analysis of our firm based on publicly available information. It is intended for informational purposes only and does not constitute financial, investment, or legal advice. Nothing here should be relied upon when making investment decisions. Readers are encouraged to conduct their own due diligence and consult a qualified financial adviser before acting on any information presented.
